Covid Monitoring Profile

COVID-19 infection could be underlying trigger for many other health complications such as heart failure, respiratory failure, stroke, and inflammatory syndromes.
A comprehensive test package to monitor your immune system for evaluation of biomarkers which may lead to manifestation of disease after COVID-19 infection.

Why to monitor?

  • People, especially, who are being admitted to ICU after COVID-19 infection were observed to have higher level of components like IL-6, D-Dimer, Platelets, Neutrophils, CRP, Ferritin etc.
  • Elevated levels of these biomarkers in the plasma have found to be associated with higher chances of being hospitalised and with higher disease severity.
  • Higher CRP & IL-6 indicates severity of infection whereas elevated creatinine observed in severe cases indicated risk of impaired kidney & liver function.
  • Refractory patients with lung complications were observed to have higher LDH, CRP, & platelet count which indicate the relation of these biomarkers with disease progression.

Schedule Covid Monitoring Sample Collection from Home

Monitoring the levels of these components can help in better prognosis and management of infection.

D-Dimer : Small fragment protein which increases with formation and breakdown of clots in the the body. D-Dimer testing in patients with COVID-19 is essential as it could be used as early marker to improve management of patients with COVID-19.

C-Reactive Protein (CRP) : Levels of CRP rises in response to inflammation in the body. Evaluation of infection and severity of inflammation could be done with measuring CRP levels.

Ferritin : As one of the makers of inflammation, ferritin levels highly correlate with severity of COVID-19. The elevated levels could be an underlying reason of secondary health complications.

CBC : Different components of the blood are checked in order to improve prognosis. Decreased levels of components like white blood cell, platelets and lymphocytes are linked to poor prognosis.

Interleukin-6 (IL-6) : Evaluation of IL-6 in the plasma can help in predicting & evaluating the outcome of inflammatory syndrome and sepsis.

Creatinine : Evaluation of this component could help in assessing acute kidney injury and to avoid long-term kidney related complications in patients with COVID-19.

Procalcitonin : Eleavted levels of this component is associated with increased tissue injury,sepsis and infection, hence evaluation of this biomarker is crucial.

Lactate Dehydrogenase (LDH) : Evaluation of LDH in plasma can help in recognising cytokine mediated tissue damage, which is associated with poor prognosis in COVID-19 patients.

N-terminal pro-B-type natriuretic peptide (NT-proBNO) & Troponin-1 (Trop-1) : Evaluation of these biomarker is essential to monitor heart related issues/cardiac injuries. Elevated levels are found to be associated with poor prognosis.